IonQ (IONQ) On Earnings Beat And DARPA Win Has Fair Value Back In Focus

IonQ (IONQ) is back in focus after a busy early August. The stock reacted to a strong second quarter, a raised 2026 revenue outlook, and a new US$28 million DARPA contract extension in quantum sensing.

See our latest analysis for IonQ.

At a share price of US$43.44, IonQ has seen short term momentum pick up, with a 7 day share price return of 4.12%, although the 90 day share price return is down 21.39%. Over a longer horizon, total shareholder returns of 1.02% over 1 year and very large gains over 3 and 5 years suggest the recent pullback comes after a strong multi year run. The latest earnings beat, raised 2026 outlook and DARPA extension give investors fresh information to weigh near term growth potential against execution and funding risks.

If IonQ's quantum progress has your attention, this can be a good moment to scan the wider opportunity set and see which other 26 quantum computing stocks might suit your watchlist.

The latest guidance raise and DARPA contract extension highlight how much investors are already paying for IonQ’s quantum story after a sharp multi year climb. Does that current price still leave enough potential reward to justify the risk?

Most Popular Narrative: 9.5% Undervalued

The most followed IonQ narrative currently points to a fair value of $48.00 against the latest close at $43.44. That gap is small enough that the story driving the valuation matters as much as the headline number.

IonQ’s business model is still early stage, but it is becoming more tangible. Revenue comes from a mix of quantum computing access, enterprise and government contracts, platform offerings, and now acquisition-supported revenue streams. The key point is that IonQ is no longer a pre-revenue or barely-revenue company. It has already crossed $100 million of annual GAAP revenue in 2025 and is guiding to more than double that in 2026.

Read the complete narrative.

The fair value story here leans heavily on rapidly scaling revenue, a richer contract backlog, and a premium future earnings multiple that usually belongs to established tech leaders. Investors may be curious which growth path, margin profile, and long term profit assumptions sit underneath that $48.00 figure.

According to HedgeY, the narrative effectively separates IonQ the business from IonQ the stock and treats the current share price as a premium on top of strong growth expectations. That makes the small undervaluation gap less important than whether the company keeps building scale across quantum computing access, sensing contracts and manufacturing partnerships like SkyWater. Investors weighing that view against their own expectations may want to focus on how quickly IonQ converts remaining performance obligations into revenue while still running at a loss.

Result: Fair Value of $48.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, IonQ’s premium valuation and ongoing losses mean that any stumble on revenue conversion or technology progress could quickly put pressure on this 9.5% undervalued narrative.

Find out about the key risks to this IonQ narrative.

Next Steps

With IonQ drawing strong opinions on both risk and reward, this is a good time to look at the numbers yourself and decide where you stand. To see the full breakdown of what investors are worried about and what they are excited about, review the 1 key reward and 3 important warning signs

Looking for more investment ideas beyond IonQ?

If IonQ has sharpened your focus, do not stop there. Widen your watchlist and compare other opportunities so you are not relying on a single story.

• Zero in on potential mispricings by scanning companies that screen as compelling on value and quality using the 49 high quality undervalued stocks.
• Strengthen your income side by reviewing stocks that feature resilient payouts and higher yields through the 8 dividend fortresses.
• Sleep easier at night by filtering for companies that show sturdier risk profiles via the 85 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com